P Schulzeck
Overview
Explore the profile of P Schulzeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haubitz M, Schulzeck P, Schellong S, Schulze M, Koch K, Brunkhorst R
Arthritis Rheum
. 1997 Oct;
40(9):1680-4.
PMID: 9324023
Objective: It has been postulated that antineutrophil cytoplasmic antibody (ANCA)-induced degranulation of primed granulocytes and monocytes is involved in the pathogenesis of ANCA-associated vasculitis. Since elastase is the major lysosomal...
2.
Schindler R, Marra M, McKelligon B, Lonnemann G, Schulzeck P, Schulze M, et al.
Clin Nephrol
. 1993 Dec;
40(6):346-51.
PMID: 7507806
Several proteins modify the biological response to lipopolysaccharide (LPS). Both bactericidal/permeability-increasing factor (BPI), a protein stored in neutrophils, and the acute phase protein LPS-binding protein (LBP) bind to LPS; however,...
3.
Schulzeck P, Olbricht C, Koch K
Clin Investig
. 1992 Feb;
70(2):99-104.
PMID: 1600346
Patients with familial hypercholesterolemia have a high incidence of coronary heart disease due to diet- and drug-resistant, elevated low-density lipoprotein cholesterol (LDL-C). Five patients with familial hypercholesterolemia and diet- and...
4.
Olbricht C, Schulzeck P
ASAIO Trans
. 1991 Jul;
37(3):M492-3.
PMID: 1751248
Five patients with diet and drug resistant familial hypercholesterolemia (FH) (low density lipoprotein [LDL] cholesterol, LDL greater than 230 mg/dl) were treated by LDL apheresis, using dextran sulfate cellulose adsorption...
5.
Schulzeck P, Bojanovski M, Jochim A, Canzler H, Bojanovski D
Lancet
. 1988 Mar;
1(8586):611-3.
PMID: 2894548
The ability of simvastatin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, to lower lipid levels in 16 patients with primary hypercholesterolaemia was compared with that of bezafibrate in a...